OncLive® On Air

Hodgkin's Lymphoma

Chemotherapy

Oncology

Colorectal Cancer

Nivolumab

Onc201

Hepatic Artery Infusion

H3K27M Mutant Diffuse Midline Gliomas

Immunotherapy

CAR T-Cell Therapy

ACTION Trial

Her2-Positive Breast Cancer

FDA Approval

Ponatinib

Swog 1826

Multiple Myeloma

Siltocaptagine Autolucel

Colorectal Cancer Management

Malignant Perivascular Epithelioid Cell Tumors

Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

30 ratings

Publishes	Daily	Episodes	500	Founded	7 years ago
Number of Listeners		Categories	ScienceHealth & Fitness

Listen to this Podcast

Guests Hosts Reviews Talking Points

Latest Episodes

S14 Ep63: Hepatic Artery Infusion Refines Liver-Directed Care for GI Cancers: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD

In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about the use of hepatic artery infusion (HAI) in colon cancer and liver cancer management. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Je... more

9 Dec 2025 • 23 min

S14 Ep62: VISION Data Show Promise of Tepotinib in Treatment-Naive NSCLC Harboring MET Exon 14 Skipping Mutations: With Catherine Shu, MD

In today’s episode, we had the pleasure of speaking with Catherine Shu, MD, about the use of tepotinib (Tepmetko) in patients with non–small cell lung cancer harboring MET exon 14 skipping mutations. Dr Shu is the Price Family Associate Professor of ... more

5 Dec 2025 • 8 min

S14 Ep61: PIPAC Reshapes Peritoneal Cancer Surgery Workflows and Outcomes: With Gregory J. Tiesi, MD, FACS, FSSO; Anthony Scholer, MD, FACS, FSSO; Benjamin Jon Golas, MD, FACS; and Eric Pletcher, MD

In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about innovations in regional cancer therapies. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center in Toms... more

3 Dec 2025 • 33 min

S14 Ep60: ctDNA Assays Are Poised to Reshape Lymphoma Treatment Strategies: With Sarah Rutherford, MD

In today’s episode, we had the pleasure of speaking with Sarah Rutherford, MD, about the evolving role of minimal residual disease (MRD) and circulating tumor DNA (ctDNA) testing for lymphoma treatment decision-making. Dr Rutherford is an associate p... more

3 Dec 2025 • 11 min

Key Facts

Accepts Guests

Accepts Sponsors

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc DocsSam and Karine

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

Research To Practice | Oncology VideosDr Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Sarah Rutherford, MD

Expert on lymphoma treatment and minimal residual disease

Not Specified

Episode: S14 Ep60: ctDNA Assays Are Poised to Reshape Lymphoma Treatment Strategies: With Sarah Rutherford, MD

Daniel Spratt, MD

Medical oncologist and expert on prostate cancer management

Episode: S14 Ep55: Advances in ADT Personalization and Molecular Imaging Shape Updated NCCN Prostate Cancer Recommendations: With Daniel Spratt, MD

Marc S. Raab, MD

Oncologist discussing the Majestic 5 study findings

Episode: S14 Ep53: Teclistamab-Based Induction Is Effective and Generates MRD Negativity in Newly Diagnosed Myeloma: With Marc S. Raab, MD

Justin Taylor, MD

Associate professor in the Division of Hematology at the University of Miami Miller School of Medicine

University of Miami Miller School of Medicine

Episode: S14 Ep51: Insights and Implications of AI’s Expanding Role in Hematologic Malignancy Care: With Justin Taylor, MD

Hira Mian

MD, MSc, FRCPC specializing in oncology

Episode: S14 Ep42: Dynamic Frailty Assessment Underscores Need for Ongoing Evaluation in Transplant-Ineligible Multiple Myeloma: With Hira Mian, MD, MSc, FRCPC

Amit Mehta, MD

Oncologist specializing in urothelial carcinoma treatment

Episode: S14 Ep36: Evolving Research Paradigms, Real-World Data, and Multidisciplinary Collaboration Enhance Bladder Cancer Management: With Amit Mehta, MD

Eunice Wang, MD

An expert in the treatment of secondary AML

Episode: S14 Ep32: Evolving Treatment Strategies and Novel Therapies Reshape Secondary AML Management: With Eunice Wang, MD

J. Thaddeus Beck, MD, FACP

Discussion expert on FDA approval of subcutaneous pembrolizumab

Episode: S14 Ep30: FDA Approval Insights: Subcutaneous Pembrolizumab for Solid Tumors: With J. Thaddeus Beck, MD, FACP

Joseph Jacob

Director of Urologic Oncology at Upstate Medical University and global primary investigator of the Sunrise 1 trial

Upstate Medical University

Episode: S14 Ep27: FDA Approval Insights: Gemcitabine Intravesical System for NMIBC: With Joseph Jacob, MD, MCR

Hosts

Gregory J. Tiesi

Chief of Surgical Oncology discussing innovative regional cancer therapies and patient management strategies.

Unknown

Host of interviews with various oncologists and discussions around oncology practices and updates.

Reviews

4.5 out of 5 stars from 30 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United States6 months ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The discussions are informative for professionals in the medical field, making it a valuable resource for anyone working in oncology.

Listeners appreciate the high-quality content focused on the latest advancements in oncology.

Top Health & Fitness Podcasts

The Dylan Gemelli PodcastDylan Gemelli

Passion Struck with John R. MilesPassion Struck Network

We're Out of TimeRichard Taite

Huberman LabScicomm Media

On Purpose with Jay ShettyiHeartPodcasts

Decoded | Unlock The Secrets of Human Behavior, Emotion and MotivationBizzie Gold | Mental Health Innovator and Break Method Founder

The Peter Attia DrivePeter Attia, MD

unPAUSED with Dr. Mary Claire HaverAudacy | Mary Claire Haver, MD

The School of GreatnessLewis Howes

The Dr. John Delony ShowRamsey Network

Talking Points

Recent interactions between the hosts and their guests.

S14 Ep62: VISION Data Show Promise of Tepotinib in Treatment-Naive NSCLC Harboring MET Exon 14 Skipping Mutations: With Catherine Shu, MD

Q: But is there anything else that you wanted to add here about some safety considerations?

In general, tepotinib was tolerated quite well; however, patients commonly experience peripheral edema, which can be bothersome and often requires management strategies.

S14 Ep62: VISION Data Show Promise of Tepotinib in Treatment-Naive NSCLC Harboring MET Exon 14 Skipping Mutations: With Catherine Shu, MD

Q: How does this evolution of data really show the importance of patients with Met positive disease really receiving the right treatment at the right time?

The update showed that it is important to treat Met exon 14 skipping mutation patients with a Met TKI as a first line, highlighting the need for thorough next-gen sequencing.

S14 Ep62: VISION Data Show Promise of Tepotinib in Treatment-Naive NSCLC Harboring MET Exon 14 Skipping Mutations: With Catherine Shu, MD

Q: Can you just start off by briefly describing the rationale and design of the Phase 2 vision trial that investigated this agent in patients with Met Exon 14 skipping mutations?

The vision trial is the largest trial that looked at patients with metastatic non-small cell lung cancer harboring Met Exon 14 skipping mutations and included both treatment naïve and previously treated patients.

S14 Ep59: Personalized Treatment Considerations Guide First-Line Chemo Use in Pancreatic Cancer: With Shubham Pant, MD, MBBS

Q: As the research kind of continues to progress, how do you see targeted therapies or other agents eventually impacting the first line of treatment paradigm here?

There is a lot of excitement about new targeted therapies, particularly KRAS inhibitors, which could provide more treatment options in the future.

S14 Ep59: Personalized Treatment Considerations Guide First-Line Chemo Use in Pancreatic Cancer: With Shubham Pant, MD, MBBS

Q: How is NaliraFox being integrated into this setting? Has there been any challenges adopting that regimen?

NaliraFox is preferred due to its superior efficacy over gemcitabine and a lower risk of neuropathy, although it may increase the risk of diarrhea.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

Content focuses on discussions with leading oncologists covering a broad spectrum of topics in oncology, including systemic therapies, surgical techniques, and innovations in radiation therapy. Episodes reflect on the latest advancements and therapeutic approaches across various cancer types, such as lung, breast, gastrointestinal, and hematologic malignancies, as well as gynecologic and genitourinary cancers. The informative interviews not only present the current state of cancer treatment but also emphasize the importance of research and clinical trials in shaping future strategies for cancer care.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 7 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Sarah Rutherford, MD
2. Daniel Spratt, MD
3. Marc S. Raab, MD
4. Justin Taylor, MD
5. Hira Mian
6. Amit Mehta, MD
7. Eunice Wang, MD
8. J. Thaddeus Beck, MD, FACP

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days